Therion Biologics' Death

Therion Biologics raised a round of funding on January 29, 2007. Investors include Dead.

Therion Biologics Corporation is engaged in the development of therapeutic vaccines for cancer and preventive vaccines for AIDS. The company has three lead programs involving multiple clinical studies…

Articles about Therion Biologics' Death: